Objectives: To asses risk factors for a first thrombotic event in antiphospholipid antibody (aPL) positive carriers and evaluate the efficacy of prophylactic treatments. Methods: Recruitment criteria were age 18–65 years, no history of thrombosis, positivity for lupus anticoagulant and/or IgG/IgM anticardiolipin antibody (aCL) on >2 occasions at least 6 weeks apart. Demographic, laboratory and clinical parameters were collected at enrolment and at the time of the thrombotic event. Results: 370 patients/subjects (mean (SD) age 34 (9.9)years) were analysed retrospectively for a mean (SD) follow-up of 59.3 (45.5) months. Thirty patients (8.1%) developed a first thrombotic event during follow-up. Hypertension and medium/high levels of IgG aCL were identified by multivariate logistic regression analysis as independent risk factors for thrombosis. Thromboprophylaxis during high-risk and long-term periods was significantly protective. Conclusions: Hypertension or medium/high titres of IgG aCL are risk factors for a first thrombotic event in asymptomatic aPL carriers and primary prophylaxis is protective.

Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicenter retrospective follow-up study / A. Ruffatti, T. Del Ross, M. Ciprian, M. Nuzzo, M. Rampudda, M.T. Bertero, R. Bergia, P. Caramaschi, D. Biasi, F. Capsoni, L. Montaguti, R. Ruffini, A. Brucato, U. Picillo, V. Fanelli, V. Riccieri, A. Piccoli, G. Valesini, A. Doria, P.L. Meroni, A. Tincani. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 68:3(2009), pp. 397-399.

Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicenter retrospective follow-up study

F. Capsoni;A. Brucato;V. Fanelli;P.L. Meroni
Penultimo
;
2009

Abstract

Objectives: To asses risk factors for a first thrombotic event in antiphospholipid antibody (aPL) positive carriers and evaluate the efficacy of prophylactic treatments. Methods: Recruitment criteria were age 18–65 years, no history of thrombosis, positivity for lupus anticoagulant and/or IgG/IgM anticardiolipin antibody (aCL) on >2 occasions at least 6 weeks apart. Demographic, laboratory and clinical parameters were collected at enrolment and at the time of the thrombotic event. Results: 370 patients/subjects (mean (SD) age 34 (9.9)years) were analysed retrospectively for a mean (SD) follow-up of 59.3 (45.5) months. Thirty patients (8.1%) developed a first thrombotic event during follow-up. Hypertension and medium/high levels of IgG aCL were identified by multivariate logistic regression analysis as independent risk factors for thrombosis. Thromboprophylaxis during high-risk and long-term periods was significantly protective. Conclusions: Hypertension or medium/high titres of IgG aCL are risk factors for a first thrombotic event in asymptomatic aPL carriers and primary prophylaxis is protective.
Settore MED/16 - Reumatologia
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/70584
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 89
  • ???jsp.display-item.citation.isi??? 72
social impact